Financial Consulate’s Maze Therapeutics MAZE Stock Holding History

Financial Consulate’s Portfolio MAZE Stock Details MAZE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.14K	Buy	+42	New	+$1.16K	﹤0.01%	1279

Other funds holding MAZE

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Financial Consulate's MAZE Position: Q3 2026 in Review

Financial Consulate opened a new position in Maze Therapeutics (MAZE) in Q3 2026: 42 shares worth $1.14K. The stake represents ﹤0.01% of the portfolio and ranks #1279 among its holdings.

11 funds tracked by Wall St. Rank hold MAZE as of Q3 2026.

Financial Consulate held 42 shares of Maze Therapeutics worth $1.14K as of Q3 2026.
Maze Therapeutics was a new Financial Consulate position in Q3 2026.
Maze Therapeutics made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1279 holding.
11 funds tracked by Wall St. Rank held Maze Therapeutics as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.